US Patent 10144931 Antisense nucleic acids

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10144931

Patent Inventor Names

Yukiko Enya0

Shin'ichi Takeda0

Yoshitsugu Aoki0

Yuichiro Tone0

Date of Patent

December 4, 2018

Patent Application Number

15759267

Date Filed

September 15, 2016

Patent Citations Received

‌

US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies

‌

US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

‌

US Patent 11369689 Muscle targeting complexes and uses thereof for treating dystrophinopathies

‌

US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies

‌

US Patent 11986537 Muscle targeting complexes and uses thereof for treating dystrophinopathies

‌

US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies

‌

US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

‌

US Patent 11497815 Muscle targeting complexes and uses thereof for treating dystrophinopathies

...

Patent Primary Examiner

‌

Sean McGarry

Patent abstract

The present invention provides an oligomer which allows exon 45 skipping in the human dystrophin gene.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10144931 Antisense nucleic acids

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10144931 Antisense nucleic acids